ABSTRACT
Background and Aim NIHSS score is higher for left versus right hemisphere strokes of equal volumes. However, differences in each vascular territory have not been evaluated yet. We hypothesized that left versus right differences are driven by the middle cerebral artery (MCA) territory, and there is no difference between hemispheres for other vascular territories.
Methods This study is based on data from 802 patients with evidence of acute or early subacute ischemic stroke. These patients had infarct restricted to one major arterial territory (MCA, n=437; PCA, n=209; ACA, n=21; vertebrobasilar, n=46) and received NIHSS and MRI at hospital admission. We examined differences in patients with left or right strokes regarding to lesion volume, NIHSS, and other covariates (age, sex, race). We used linear models to test the effects of these covariates on NIHSS. We looked at the whole sample as well as in the sample stratified by NIHSS (<=5 or >5) and by lesion location (MCA or PCA).
Results Patients with left MCA strokes had significantly higher NIHSS than those with right strokes. Only patients with MCA strokes showed NIHSS score affected by the hemisphere when controlling for stroke volume and patient’s age. This difference was driven by the more severe strokes (NIHSS>5). In addition, stroke volume and patient’s age significantly correlated with NIHSS.
Conclusion Right MCA infarcts are larger than left MCA infarcts associated with a given NIHSS score, after accounting for other significant associations, such as patient’s age. It is important to consider this systematic bias in the NIHSS when using the score for inclusion criteria for treatment or trials. Patients with right MCA stroke may be under-treated and left with disabling deficits that are not captured by the NIHSS.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research was supported in part by the National Institute of Deaf and Communication Disorders,NIDCD, through R01 DC05375, R01 DC015466, P50 DC01466
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
We have complied with all relevant ethical regulations and the guidelines of the Johns Hopkins Institutional Review Board, that approved the present study (IRB00290649)
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The data that supports this study is available in Zenodo https://doi.org/10.5281/zenodo.5722286
